Breakthrough diagnostics platform
Location: United States, California, Hayward
Employees: 11-50
Total raised: $31M
Founded date: 2018
Investors 2
| Date | Name | Website |
| 04.11.2023 | Yu Galaxy | yugalaxy.c... |
| 08.06.2022 | Manta Ray ... | mantaray.v... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 11.07.2025 | Series B | $31M | - |
Mentions in press and media 4
| Date | Title | Description |
| 11.07.2025 | Aqtual Pulls In $31M Series B Funding | HAYWARD, CA, Aqtual, a precision medicine company using its novel active chromatin cell-free DNA (cfDNA) platform to develop products for chronic diseases and oncology, has raised $31 million in Series B funding. >> Click here for mo... |
| 10.07.2025 | Aqtual Raises $31M in Series B Funding | Aqtual, a Hayward, CA-based precision medicine company providing an active chromatin cell-free DNA (cfDNA) platform, raised $31M in Series B funding. Backers included Bold Capital, Bold Longevity Growth Fund, Genoa Ventures, Manta Ray Ventu... |
| 02.01.2024 | Health | A new test could save arthritis patients time, money and pain. But will it be used? | Arthur Allen | KFF Health News (TNS) SAN DIEGO — Erinn Maury knew Remicade wasn’t the right drug for Patti Schulte, a rheumatoid arthritis patient the physician saw at her Millersville, Maryland, practice. Schulte’s swollen, painful joints ... |
| - | Aqtual | “Clinically-Actionable Insights From Circulating DNA In Blood” |